PFM Health Sciences’s Cooper Companies COO Stock Holding History

PFM Health Sciences’s Portfolio COO Stock Details COO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.1M	Buy	169,829 +69,027	+68%	+$5.46M	1.11%	27
2025 Q4	$8.26M	Buy	100,802 +26,439	+36%	+$1.98M	0.82%	41
2025 Q3	$5.1M	Buy	+74,363	New	+$5.27M	0.39%	49
2014 Q1	–	Sell	-764,612	Closed	-$23.7M	–	81
2013 Q4	$23.7M	Buy	764,612 +386,444	+102%	+$12.3M	0.48%	44
2013 Q3	$12.3M	Sell	378,168 -588	-0.2%	-$19K	0.3%	53
2013 Q2	$11.3M	Buy	+378,756	New	+$10.6M	0.23%	62

Other funds holding COO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PFM Health Sciences's COO Position: Q1 2026 in Review

PFM Health Sciences increased its Cooper Companies (COO) stake by 68% in Q1 2026, buying an estimated $5.46M and bringing the position to 169,829 shares worth $12.1M. The position accounts for 1.11% of the portfolio, ranked #27.

PFM Health Sciences first reported a position in COO in Q2 2013 and has held it in 6 quarters since. The position peaked at $23.7M in Q4 2013. 675 funds tracked by Wall St. Rank hold COO as of Q1 2026.

PFM Health Sciences held 169,829 shares of Cooper Companies worth $12.1M as of Q1 2026.
PFM Health Sciences bought 69,027 Cooper Companies shares in Q1 2026, an estimated $5.46M.
Cooper Companies made up 1.11% of PFM Health Sciences's portfolio in Q1 2026, its #27 holding.
PFM Health Sciences first reported a position in Cooper Companies in Q2 2013 and has held it in 6 quarters since.
PFM Health Sciences's Cooper Companies position peaked at $23.7M in Q4 2013.
675 funds tracked by Wall St. Rank held Cooper Companies as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.